Mono, di and tri-mannopyranosyl phosphates as mannose-1-phosphate prodrugs for potential CDG-Ia therapy R Hardré, A Khaled, A Willemetz, T Dupré, S Moore, C Gravier-Pelletier, ... Bioorganic & Medicinal Chemistry Letters 17 (1), 152-155, 2007 | 44 | 2007 |
Methoxyphenyl N-sulfamoyloxazolidinone Cu (II) and Co (II) complexes: Synthesis, DFT/B3LYP (B2PLYP) study and molecular docking D Guibedj, H Bougherara, M Kadri, H Akkari, M Berredjem, A Khaled Journal of Molecular Structure 1202, 127190, 2020 | 11 | 2020 |
New Cu (II) and Zn (II) complexes with diethyl phenyl (N-phenylsulfamoylamino) methyl phosphonate: Synthesis, characterisation, DFT/M11 studies, NBO, DOS, QTAIM and RDG analysis A Khaled, R Kadri, M Kadri, M Berredjem Journal of Molecular Structure 1263, 133003, 2022 | 9 | 2022 |
Synthesis of bis-(2, 3, 4, 6-tetra-O-acetyl-α-d-mannopyranosyl)-l-serinyl phosphate, as a prodrug of mannose-1-phosphate A Khaled, C Gravier-Pelletier, Y Le Merrer Tetrahedron: Asymmetry 18 (18), 2121-2124, 2007 | 4 | 2007 |
Mannosyl-1 phosphates, preparation method and therapeutic use, in particular against the cdg-ia syndrome C Gravier-Pelletier, R Hardre, A Khaled, Y Le Merrer US Patent App. 12/279,876, 2009 | 2 | 2009 |
Les complexes des ions Cu (II) et Zn (II) avec le diéthyl phényl (N-phénylsulfamoylamino) méthyl phosphonate: Synthèse, caractérisation, étude par DFT/M11 et docking moléculaire A KHALED | | 2022 |